Ganglioside GD3 May Suppress the Functional Activities of Benign Skin T Cells in Cutaneous T-Cell Lymphoma

In cutaneous T-cell lymphoma (CTCL), which arises from skin-tropic memory T cells, malignant T cells and benign T cells are confined in the same skin lesions. It is thus difficult to evaluate the phenotypic characteristics and functional activities of benign T cells in CTCL. Disialoganglioside with...

Full description

Bibliographic Details
Main Authors: Miki Kume, Eiji Kiyohara, Yutaka Matsumura, Hanako Koguchi-Yoshioka, Atsushi Tanemura, Yuma Hanaoka, Mifue Taminato, Hiroki Tashima, Koichi Tomita, Tateki Kubo, Rei Watanabe, Manabu Fujimoto
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.651048/full
_version_ 1829138520270176256
author Miki Kume
Eiji Kiyohara
Yutaka Matsumura
Hanako Koguchi-Yoshioka
Hanako Koguchi-Yoshioka
Atsushi Tanemura
Yuma Hanaoka
Mifue Taminato
Hiroki Tashima
Koichi Tomita
Tateki Kubo
Rei Watanabe
Rei Watanabe
Manabu Fujimoto
author_facet Miki Kume
Eiji Kiyohara
Yutaka Matsumura
Hanako Koguchi-Yoshioka
Hanako Koguchi-Yoshioka
Atsushi Tanemura
Yuma Hanaoka
Mifue Taminato
Hiroki Tashima
Koichi Tomita
Tateki Kubo
Rei Watanabe
Rei Watanabe
Manabu Fujimoto
author_sort Miki Kume
collection DOAJ
description In cutaneous T-cell lymphoma (CTCL), which arises from skin-tropic memory T cells, malignant T cells and benign T cells are confined in the same skin lesions. It is thus difficult to evaluate the phenotypic characteristics and functional activities of benign T cells in CTCL. Disialoganglioside with three glycosyl groups (GD3) is increasingly expressed on the surface of solid malignant tumor cells and takes part in tumor progression and suppression of tumor immunity. However, the role of GD3 in CTCL is not well-understood. In this study, the malignant and benign T cells in CTCL skin lesions were distinguished by flow cytometry and their phenotypic characteristics were compared with those of T cells from control skin specimens. In CTCL skin lesions, the benign T cells included limited resident memory T cells (TRM), which are sessile in skin and known to exert strong antitumor function. The benign T cells showed diminished Th17 property, and the expression of GD3 was high in the malignant T cells. The expression of GD3 in the malignant T cells inversely correlated with IL-17A production from the benign CD4 T cells. GD3 from the malignant T cells was implied to be involved in suppressing the Th17 activity of the benign T cells independent of the regulation of TRM differentiation in CTCL. Revealing the role of GD3 in inhibiting the production of IL-17A in CTCL would aid the understanding of the suppressive mechanism of the antitumor activity by malignant tumor cells.
first_indexed 2024-12-14T19:18:33Z
format Article
id doaj.art-6c52559023404adda83e03f5f6112834
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-14T19:18:33Z
publishDate 2021-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-6c52559023404adda83e03f5f61128342022-12-21T22:50:26ZengFrontiers Media S.A.Frontiers in Immunology1664-32242021-03-011210.3389/fimmu.2021.651048651048Ganglioside GD3 May Suppress the Functional Activities of Benign Skin T Cells in Cutaneous T-Cell LymphomaMiki Kume0Eiji Kiyohara1Yutaka Matsumura2Hanako Koguchi-Yoshioka3Hanako Koguchi-Yoshioka4Atsushi Tanemura5Yuma Hanaoka6Mifue Taminato7Hiroki Tashima8Koichi Tomita9Tateki Kubo10Rei Watanabe11Rei Watanabe12Manabu Fujimoto13Department of Dermatology, Course of Integrated Medicine, Graduate School of Medicine, Osaka University, Osaka, JapanDepartment of Dermatology, Course of Integrated Medicine, Graduate School of Medicine, Osaka University, Osaka, JapanDepartment of Dermatology, Course of Integrated Medicine, Graduate School of Medicine, Osaka University, Osaka, JapanDepartment of Dermatology, Course of Integrated Medicine, Graduate School of Medicine, Osaka University, Osaka, JapanDepartment of Integrative Medicine for Allergic and Immunological Diseases, Course of Integrated Medicine, Graduate School of Medicine, Osaka University, Osaka, JapanDepartment of Dermatology, Course of Integrated Medicine, Graduate School of Medicine, Osaka University, Osaka, JapanDepartment of Dermatology, Course of Integrated Medicine, Graduate School of Medicine, Osaka University, Osaka, JapanDepartment of Plastic Surgery, Course of Organ Regulation Medicine, Graduate School of Medicine, Osaka University, Osaka, JapanDepartment of Plastic Surgery, Course of Organ Regulation Medicine, Graduate School of Medicine, Osaka University, Osaka, JapanDepartment of Plastic Surgery, Course of Organ Regulation Medicine, Graduate School of Medicine, Osaka University, Osaka, JapanDepartment of Plastic Surgery, Course of Organ Regulation Medicine, Graduate School of Medicine, Osaka University, Osaka, JapanDepartment of Dermatology, Course of Integrated Medicine, Graduate School of Medicine, Osaka University, Osaka, JapanDepartment of Integrative Medicine for Allergic and Immunological Diseases, Course of Integrated Medicine, Graduate School of Medicine, Osaka University, Osaka, JapanDepartment of Dermatology, Course of Integrated Medicine, Graduate School of Medicine, Osaka University, Osaka, JapanIn cutaneous T-cell lymphoma (CTCL), which arises from skin-tropic memory T cells, malignant T cells and benign T cells are confined in the same skin lesions. It is thus difficult to evaluate the phenotypic characteristics and functional activities of benign T cells in CTCL. Disialoganglioside with three glycosyl groups (GD3) is increasingly expressed on the surface of solid malignant tumor cells and takes part in tumor progression and suppression of tumor immunity. However, the role of GD3 in CTCL is not well-understood. In this study, the malignant and benign T cells in CTCL skin lesions were distinguished by flow cytometry and their phenotypic characteristics were compared with those of T cells from control skin specimens. In CTCL skin lesions, the benign T cells included limited resident memory T cells (TRM), which are sessile in skin and known to exert strong antitumor function. The benign T cells showed diminished Th17 property, and the expression of GD3 was high in the malignant T cells. The expression of GD3 in the malignant T cells inversely correlated with IL-17A production from the benign CD4 T cells. GD3 from the malignant T cells was implied to be involved in suppressing the Th17 activity of the benign T cells independent of the regulation of TRM differentiation in CTCL. Revealing the role of GD3 in inhibiting the production of IL-17A in CTCL would aid the understanding of the suppressive mechanism of the antitumor activity by malignant tumor cells.https://www.frontiersin.org/articles/10.3389/fimmu.2021.651048/fullcutaneous T-cell lymphomagangliosideGD3resident memory T cellsantitumor immunity
spellingShingle Miki Kume
Eiji Kiyohara
Yutaka Matsumura
Hanako Koguchi-Yoshioka
Hanako Koguchi-Yoshioka
Atsushi Tanemura
Yuma Hanaoka
Mifue Taminato
Hiroki Tashima
Koichi Tomita
Tateki Kubo
Rei Watanabe
Rei Watanabe
Manabu Fujimoto
Ganglioside GD3 May Suppress the Functional Activities of Benign Skin T Cells in Cutaneous T-Cell Lymphoma
Frontiers in Immunology
cutaneous T-cell lymphoma
ganglioside
GD3
resident memory T cells
antitumor immunity
title Ganglioside GD3 May Suppress the Functional Activities of Benign Skin T Cells in Cutaneous T-Cell Lymphoma
title_full Ganglioside GD3 May Suppress the Functional Activities of Benign Skin T Cells in Cutaneous T-Cell Lymphoma
title_fullStr Ganglioside GD3 May Suppress the Functional Activities of Benign Skin T Cells in Cutaneous T-Cell Lymphoma
title_full_unstemmed Ganglioside GD3 May Suppress the Functional Activities of Benign Skin T Cells in Cutaneous T-Cell Lymphoma
title_short Ganglioside GD3 May Suppress the Functional Activities of Benign Skin T Cells in Cutaneous T-Cell Lymphoma
title_sort ganglioside gd3 may suppress the functional activities of benign skin t cells in cutaneous t cell lymphoma
topic cutaneous T-cell lymphoma
ganglioside
GD3
resident memory T cells
antitumor immunity
url https://www.frontiersin.org/articles/10.3389/fimmu.2021.651048/full
work_keys_str_mv AT mikikume gangliosidegd3maysuppressthefunctionalactivitiesofbenignskintcellsincutaneoustcelllymphoma
AT eijikiyohara gangliosidegd3maysuppressthefunctionalactivitiesofbenignskintcellsincutaneoustcelllymphoma
AT yutakamatsumura gangliosidegd3maysuppressthefunctionalactivitiesofbenignskintcellsincutaneoustcelllymphoma
AT hanakokoguchiyoshioka gangliosidegd3maysuppressthefunctionalactivitiesofbenignskintcellsincutaneoustcelllymphoma
AT hanakokoguchiyoshioka gangliosidegd3maysuppressthefunctionalactivitiesofbenignskintcellsincutaneoustcelllymphoma
AT atsushitanemura gangliosidegd3maysuppressthefunctionalactivitiesofbenignskintcellsincutaneoustcelllymphoma
AT yumahanaoka gangliosidegd3maysuppressthefunctionalactivitiesofbenignskintcellsincutaneoustcelllymphoma
AT mifuetaminato gangliosidegd3maysuppressthefunctionalactivitiesofbenignskintcellsincutaneoustcelllymphoma
AT hirokitashima gangliosidegd3maysuppressthefunctionalactivitiesofbenignskintcellsincutaneoustcelllymphoma
AT koichitomita gangliosidegd3maysuppressthefunctionalactivitiesofbenignskintcellsincutaneoustcelllymphoma
AT tatekikubo gangliosidegd3maysuppressthefunctionalactivitiesofbenignskintcellsincutaneoustcelllymphoma
AT reiwatanabe gangliosidegd3maysuppressthefunctionalactivitiesofbenignskintcellsincutaneoustcelllymphoma
AT reiwatanabe gangliosidegd3maysuppressthefunctionalactivitiesofbenignskintcellsincutaneoustcelllymphoma
AT manabufujimoto gangliosidegd3maysuppressthefunctionalactivitiesofbenignskintcellsincutaneoustcelllymphoma